J
Jumi Kim
Researcher at Samsung
Publications - 27
Citations - 804
Jumi Kim is an academic researcher from Samsung. The author has contributed to research in topics: Embryonic stem cell & Cellular differentiation. The author has an hindex of 13, co-authored 27 publications receiving 737 citations.
Papers
More filters
Journal ArticleDOI
Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell–Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia
Seung Woo Cho,Sung Hwan Moon,Soo-Hong Lee,Sun-Woong Kang,Jumi Kim,Jae Min Lim,Hyo-Soo Kim,Byung-Soo Kim,Hyung-Min Chung +8 more
TL;DR: It is demonstrated that hESC-EC transplantation improves blood perfusion and limb salvage by facilitating postnatal neovascularization in a mouse model of hindlimb ischemia and might be useful as an alternative cell source for angiogenic therapy.
Journal ArticleDOI
Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells.
TL;DR: The results suggest that secretory factors released from stem cells could be an important mediator of stem cell therapy in ischemic tissue diseases.
Journal ArticleDOI
Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Jung Il Chae,Dong Wook Kim,Nayeon Lee,Young Joo Jeon,Iksoo Jeon,Ji-Hye Kwon,Jumi Kim,Yunjo Soh,Dong-Seok Lee,Kang Seok Seo,Nag Jin Choi,Byoung Chul Park,Sunghyun Kang,Joohyun Ryu,Seung Hun Oh,Dong Ah Shin,Dong Ryul Lee,Jeong Tae Do,In-Hyun Park,In-Hyun Park,George Q. Daley,Jihwan Song +21 more
TL;DR: Results demonstrate that HD-iPSCs can provide a unique cellular disease model system to understand the pathogenesis and neurodegeneration mechanisms in HD, and the identified proteins from the present study may serve as potential targets for developing future HD therapeutics.
Journal ArticleDOI
Comparative Analysis of Human Mesenchymal Stem Cells Derived From Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy.
TL;DR: The results indicate that primitive PL‐ MSCs have biological advantages relative to those from other sources, making PL‐MSCs a useful model for clinical applications of cell therapy.
Journal ArticleDOI
Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells.
Jung Ki Yoo,Jumi Kim,Seong Jun Choi,Hye Min Noh,Young Do Kwon,Hanna Yoo,Hyo seon Yi,Hyung-Min Chung,Jin Kyeoung Kim +8 more
TL;DR: The results demonstrate that several novel miRNAs perform critical roles in human endothelial cell development, including to directly suppress their target genes, popularly known as endothelialcell markers.